![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Single-dose pharmacokinetics of VIR-3434, a novel neutralizing
monoclonal antibody, in participants with chronic hepatitis B virus infection
|
|
|
EASL 2023 June 21-24 Vienna
Sneha V. Gupta1, Sophia Elie1, Andre Arizpe1, George Hristopoulos1, Pan Wu1, Daniel Cloutier1, Maribel Reyes1
1Vir Biotechnology, Inc., San Francisco, CA
![0627231](../images/062723/062623-26/0627231.gif)
![0627232](../images/062723/062623-26/0627232.gif)
![0627233](../images/062723/062623-26/0627233.gif)
![0627234](../images/062723/062623-26/0627234.gif)
![0627235](../images/062723/062623-26/0627235.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|